PHC Group Executive and Leadership Team

Kay Deguchi, the Chief Executive Officer at PHC Group, directs the overarching strategic vision for global diagnostic services. Deguchi architects long-term growth initiatives by aligning medical technology development with evolving healthcare market demands. By fostering partnerships with international medical facilities, the Chief Executive Officer ensures the seamless integration of digital platforms into clinical workflows. Kay Deguchi maintains rigorous oversight of corporate expansion across Asia, Europe, and North America, ensuring consistent delivery of high-quality diagnostic tools. This leadership role involves constant collaboration with the Board to refine the company mission of improving patient outcomes through precision technology. Through the implementation of scalable business models, Deguchi drives operational excellence and sustains the competitive position of the organization within the global healthcare sector. The Chief Executive Officer prioritizes innovation to meet the complex needs of both business and consumer markets.

Kyoko Deguchi, the President & Representative & Director & Chief Executive Officer at PHC Group, manages corporate governance and representative duties for the entire organization. Deguchi oversees the structural integrity of the company, ensuring compliance with international regulatory standards across all diagnostic product lines. By coordinating with the Board of Directors, the President & Representative & Director & Chief Executive Officer establishes the framework for sustainable corporate development. Kyoko Deguchi drives the execution of high-level policies that support the deployment of medical health solutions in diverse global markets. This role requires balancing administrative precision with strategic foresight to maintain the reputation of the firm. Through the management of organizational resources, Deguchi secures the stability of the business model. The President & Representative & Director & Chief Executive Officer focuses on long-term value creation, ensuring that every diagnostic service aligns with the core mission of enhancing healthcare accessibility worldwide.

Kaiju Yamaguchi, the Executive Corporate Officer and Chief Financial Officer at PHC Group, directs all fiscal planning and capital allocation strategies. Yamaguchi oversees the financial health of the organization, ensuring that investments in diagnostic technologies yield measurable returns across global operations. By managing the balance sheet and optimizing cost structures, the Executive Corporate Officer and Chief Financial Officer supports the expansion of digital platforms in North America and beyond. Kaiju Yamaguchi collaborates with other C-suite leaders to align budgetary priorities with the overarching mission of providing comprehensive medical tools. This leadership role involves rigorous analysis of market trends to mitigate financial risks while identifying new growth opportunities. Through the implementation of robust financial controls, Yamaguchi ensures the long-term viability of the company. The Executive Corporate Officer and Chief Financial Officer maintains transparency with stakeholders, driving fiscal discipline to support the continuous innovation of healthcare solutions.

Koichiro Sato, the Chief Operating Officer & Head of Diabetes Management Business at PHC Group, directs the daily operational workflows and the specialized diabetes care division. Sato oversees the production and distribution of diagnostic tools, ensuring that medical facilities receive high-performance equipment on time. By focusing on the diabetes management segment, the Chief Operating Officer & Head of Diabetes Management Business architects specific solutions that address chronic health conditions through advanced digital platforms. Koichiro Sato manages the supply chain and operational efficiency across international regions, ensuring that the company meets the needs of both business and consumer markets. This leadership role involves coordinating cross-functional teams to streamline product development cycles. Through the optimization of internal processes, Sato drives the delivery of reliable healthcare technologies. The Chief Operating Officer & Head of Diabetes Management Business ensures that operational output remains consistent with the high standards required for global medical diagnostic services.